Public Cannabis Company Revenue Tracker

The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5m per quarter. This data-driven, fact-based tracker will continually update based on new filings so that readers can stay up to date. Companies must file with the SEC or SEDAR to be considered for inclusion.

U.S. Cannabis Market
Company Name Stock Symbol Quarter Ended Quarterly Sales Y/Y Growth Next Financials
Terra Tech (OTCQX: TRTC) 06/30/17 $6.05m 61% ~11/09/17
Kush Bottles (OTCQB: KSHB) 05/31/17 $4.72m 103% ~11/29/17
GrowGeneration (OTCQB: GRWG) 06/30/17 $4.11m 116%  ~11/14/17
CV Sciences (OTCQB: CVSI) 06/30/17 $4.08m 64% ~11/14/17
GW Pharma (NASDAQ: GWPH) 06/30/17 $3.14m 3% ~12/14/17
Canadian Cannabis Market
Company Name Stock Symbol Quarter Ended Quarterly Sales Y/Y Growth Next Financials
Canopy Growth (TSX: WEED) 06/30/17 C$15.87m 127%  ~11/14/17
MedReleaf (TSX: LEAF) 06/30/17 C$10.46m 19% ~11/14/17
Aphria (TSX: APH) 05/31/17 C$5.72m 106% ~10/16/17
Aurora Cannabis (TSX: ACB) 03/31/17 C$5.18m 2263%  ~9/28/17
CanniMed Therapeutics (TSX: CMED) 04/30/17 C$3.69m 66%  ~9/14/17
Namaste Technologies (CSE: N) 05/31/17 C$3.16m 328% ~12/29/17

Note: Sales are cannabis-only if the company breaks out revenue by segment. For more information or questions, please email us. The Public Cannabis Company Revenue Tracker by New Cannabis Ventures is not a recommendation of any company and you should not use it as investment advice. A tilde next to a date means approximate date. All computations are derived from SEC or SEDAR filings.

Latest News
Get The App

Download the free “New Cannabis Ventures” app on the iOS App Store or Google Play and get real-time push notifications straight to your phone on the latest breaking news and exclusives published.



NCV Media

Thank you for reading

New Cannabis Ventures

Contributing original content and curating quality news on only the most promising cannabis companies and the most influential investors.